International Patent: NK CELLS WITH IMPROVED ABILITY TO TARGET AND KILL CANCER CELLS AND USE THEREOF

GENEVA, June 24 -- THERABEST CO.,LTD filed a patent application (KR2025/019951) for “NK CELLS WITH IMPROVED ABILITY TO TARGET AND KILL CANCER CELLS AND USE THEREOF”. With publication no. WO/2026/117036, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: C12N 5/0783

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....